162 related articles for article (PubMed ID: 21545833)
1. Effect of short term and chronic administration of Sutherlandia frutescens on pharmacokinetics of nevirapine in rats.
Minocha M; Mandava NK; Kwatra D; Pal D; Folk WR; Earla R; Mitra AK
Int J Pharm; 2011 Jul; 413(1-2):44-50. PubMed ID: 21545833
[TBL] [Abstract][Full Text] [Related]
2. Impact of traditional medicinal plant extracts on antiretroviral drug absorption.
Brown L; Heyneke O; Brown D; van Wyk JP; Hamman JH
J Ethnopharmacol; 2008 Oct; 119(3):588-92. PubMed ID: 18640255
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic interaction between nevirapine and nortriptyline in rats: inhibition of nevirapine metabolism by nortriptyline.
Usach I; Melis V; Gandía P; Peris JE
Antimicrob Agents Chemother; 2014 Dec; 58(12):7041-8. PubMed ID: 25224004
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450.
Erickson DA; Mather G; Trager WF; Levy RH; Keirns JJ
Drug Metab Dispos; 1999 Dec; 27(12):1488-95. PubMed ID: 10570031
[TBL] [Abstract][Full Text] [Related]
5. Interactions between phytochemical components of Sutherlandia frutescens and the antiretroviral, atazanavir in vitro: implications for absorption and metabolism.
Müller AC; Patnala S; Kis O; Bendayan R; Kanfer I
J Pharm Pharm Sci; 2012; 15(2):221-33. PubMed ID: 22579002
[TBL] [Abstract][Full Text] [Related]
6. Sutherlandia frutescens prevents changes in diabetes-related gene expression in a fructose-induced insulin resistant cell model.
Williams S; Roux S; Koekemoer T; van de Venter M; Dealtry G
J Ethnopharmacol; 2013 Mar; 146(2):482-9. PubMed ID: 23376105
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic interaction between nevirapine and ethinyl estradiol/norethindrone when administered concurrently to HIV-infected women.
Mildvan D; Yarrish R; Marshak A; Hutman HW; McDonough M; Lamson M; Robinson P
J Acquir Immune Defic Syndr; 2002 Apr; 29(5):471-7. PubMed ID: 11981363
[TBL] [Abstract][Full Text] [Related]
8. Sex-dependent metabolism of nevirapine in rats: impact on plasma levels, pharmacokinetics and interaction with nortriptyline.
Usach I; Compañ P; Peris JE
Int J Antimicrob Agents; 2018 May; 51(5):707-713. PubMed ID: 29309900
[TBL] [Abstract][Full Text] [Related]
9. In vitro assessment of competitive and time-dependent inhibition of the nevirapine metabolism by nortriptyline in rats.
Usach I; Ferrer JM; Peris JE
Biochem Pharmacol; 2018 Aug; 154():1-9. PubMed ID: 29674001
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of nevirapine when given with isoniazid in South African HIV-infected individuals.
Decloedt EH; Mwansa-Kambafwile J; van der Walt JS; McIlleron H; Denti P; Smith P; Wiesner L; Rangaka M; Wilkinson RJ; Maartens G
Int J Tuberc Lung Dis; 2013 Mar; 17(3):333-5. PubMed ID: 23407222
[TBL] [Abstract][Full Text] [Related]
11. Differential signaling involved in Sutherlandia frutescens-induced cell death in MCF-7 and MCF-12A cells.
Vorster C; Stander A; Joubert A
J Ethnopharmacol; 2012 Mar; 140(1):123-30. PubMed ID: 22266339
[TBL] [Abstract][Full Text] [Related]
12. Sutherlandia frutescens extracts can induce apoptosis in cultured carcinoma cells.
Chinkwo KA
J Ethnopharmacol; 2005 Apr; 98(1-2):163-70. PubMed ID: 15763378
[TBL] [Abstract][Full Text] [Related]
13. The potential of Sutherlandia frutescens for herb-drug interaction.
Fasinu PS; Gutmann H; Schiller H; James AD; Bouic PJ; Rosenkranz B
Drug Metab Dispos; 2013 Feb; 41(2):488-97. PubMed ID: 23209194
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin.
Avihingsanon A; Manosuthi W; Kantipong P; Chuchotaworn C; Moolphate S; Sakornjun W; Gorowara M; Yamada N; Yanai H; Mitarai S; Ishikawa N; Cooper DA; Phanuphak P; Burger D; Ruxrungtham K
Antivir Ther; 2008; 13(4):529-36. PubMed ID: 18672531
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of nevirapine analogs to study the metabolic activation of nevirapine.
Tateishi Y; Ohe T; Yasuda D; Takahashi K; Nakamura S; Kazuki Y; Mashino T
Drug Metab Pharmacokinet; 2020 Apr; 35(2):238-243. PubMed ID: 32184040
[TBL] [Abstract][Full Text] [Related]
16. Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women.
Dong BJ; Zheng Y; Hughes MD; Frymoyer A; Verotta D; Lizak P; Sawe F; Currier JS; Lockman S; Aweeka FT;
AIDS; 2012 Apr; 26(7):833-41. PubMed ID: 22301417
[TBL] [Abstract][Full Text] [Related]
17. Influence of Sutherlandia frutescens extracts on cell numbers, morphology and gene expression in MCF-7 cells.
Stander BA; Marais S; Steynberg TJ; Theron D; Joubert F; Albrecht C; Joubert AM
J Ethnopharmacol; 2007 Jun; 112(2):312-8. PubMed ID: 17433588
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of nevirapine extended-release once daily versus nevirapine immediate-release twice-daily in treatment-naive HIV-1-infected patients.
Gathe J; Andrade-Villanueva J; Santiago S; Horban A; Nelson M; Cahn P; Bogner J; Spencer D; Podzamczer D; Yong CL; Nguyen T; Zhang W; Drulak M; Quinson AM
Antivir Ther; 2011; 16(5):759-69. PubMed ID: 21817198
[TBL] [Abstract][Full Text] [Related]
19. Increasing nevirapine dose can overcome reduced bioavailability due to rifampicin coadministration.
Ramachandran G; Hemanthkumar AK; Rajasekaran S; Padmapriyadarsini C; Narendran G; Sukumar B; Sathishnarayan S; Raja K; Kumaraswami V; Swaminathan S
J Acquir Immune Defic Syndr; 2006 May; 42(1):36-41. PubMed ID: 16639340
[TBL] [Abstract][Full Text] [Related]
20. The mutagenic and antimutagenic activity of Sutherlandia frutescens extracts and marker compounds.
Ntuli SSBN; Gelderblom WCA; Katerere DR
BMC Complement Altern Med; 2018 Mar; 18(1):93. PubMed ID: 29544492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
